The design and synthesis of the Angiotensin Converting Enzyme inhibitor Cilazapril and related bicyclic compounds
- 1 January 1986
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Journal of the Chemical Society, Perkin Transactions 1
- No. 6,p. 1011-1019
- https://doi.org/10.1039/p19860001011
Abstract
The postulated binding functions for the active site of Angiotensin Converting Enzyme (A.C.E.), derived in an earlier study, have made possible the design of improved inhibitors. Consequently, (1S,9S)-9-[(1S)-(ethoxycarbonyl)-3-phenylpropylamino]octahydro-10-oxo-6H-pyridazo[1,2-a][1,2]diazepine-1-carboxylic acid (Cilazapril), and related compounds, have been synthesized. They are very active inhibitors of A.C.E. and are highly potent antihypertensives in vivo.This publication has 2 references indexed in Scilit:
- Biological Properties of the Angiotensin-Converting Enzyme Inhibitor CilazaprilJournal of Cardiovascular Pharmacology, 1985
- Design of Specific Inhibitors of Angiotensin-Converting Enzyme: New Class of Orally Active Antihypertensive AgentsScience, 1977